[DOI] [PMC free article] [PubMed] [Google Scholar] Di Marco E, Gray SP, Kennedy K, Szyndralewiez C, Lyle AN, Lassgue B, Griendling KK, Cooper ME, Schmidt HHHW, Jandeleit-Dahm KAM
Just like any pharmaceutical medication, there are side effects and disclaimers
The dietary protocol most prescribed among the consensus members is cKD (60%), followed by MAD (25%), primarily used in adolescent-adult patients, and MCT-KD (10%), used in patients with compliance problems, while LGIT is prescribed in ~5% (Figure 1)
(2021), reported that preclinical evidence in rodent models of EAE strongly supports cannabidiol as an effective immunomodulating and disease-modifying drug
Foxman warns
Coverage for sleep apnea Zepbound's second FDA indication gets its own section of cnf_684: "Obstructive Sleep Apnea, Moderate to Severe, in a Patient with Obesity" approved for 1 year when you're 18 or older with a baseline BMI of 30 or higher and a sleep study showing an apnea-hypopnea index of 15 or more events per hour
